{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T23:18:46Z","timestamp":1720221526407},"reference-count":32,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Mol Med"],"DOI":"10.3892\/ijmm.2020.4500","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T11:36:42Z","timestamp":1581593802000},"source":"Crossref","is-referenced-by-count":0,"title":["Overexpression of IFIT2 inhibits the proliferation of chronic myeloid leukemia cells by regulating the BCR\u2011ABL\/AKT\/mTOR pathway"],"prefix":"10.3892","author":[{"given":"Zhanglin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Blood Transfusion, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Stomatology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinal Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Clinal Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Clinal Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinal Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lagen","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Clinal Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caifeng","family":"Xie","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi 330031, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"key20200713162517_b1-ijmm-45-04-1187","first-page":"169","article-title":"Chronic myelogenous leukemia: update on biology and treatment","volume":"13","author":"Faderl","year":"1999","journal-title":"Oncology (Williston Park)"},{"key":"key20200713162517_b2-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1126\/science.3460176","article-title":"The chronic myelogenous leukemia-specific p210 protein is the product of the bcr\/abl hybrid gene","volume":"233","author":"Ben-Neriah","year":"1986","journal-title":"Science"},{"key":"key20200713162517_b3-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key20200713162517_b4-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"key20200713162517_b5-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/PPO.0b013e31823dec8d","article-title":"Evolution of therapies for chronic myelogenous leukemia","volume":"17","author":"Santos","year":"2011","journal-title":"Cancer J"},{"key":"key20200713162517_b6-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccr.2014.07.006","article-title":"BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia","volume":"26","author":"Zabriskie","year":"2014","journal-title":"Cancer Cell"},{"key":"key20200713162517_b7-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer Cell"},{"key":"key20200713162517_b8-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","article-title":"Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia","volume":"8","author":"Apperley","year":"2007","journal-title":"Lancet Oncol"},{"key":"key20200713162517_b9-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias","volume":"354","author":"Talpaz","year":"2006","journal-title":"N Engl J Med"},{"key":"key20200713162517_b10-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ccr.2009.09.028","article-title":"AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance","volume":"16","author":"O'Hare","year":"2009","journal-title":"Cancer Cell"},{"key":"key20200713162517_b11-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/17474086.2016.1232163","article-title":"Ponatinib in the therapy of chronic myeloid leukemia","volume":"9","author":"Poch Martell","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"key20200713162517_b12-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"532","DOI":"10.7326\/0003-4819-114-7-532","article-title":"Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients","volume":"114","author":"Talpaz","year":"1991","journal-title":"Ann Intern Med"},{"key":"key20200713162517_b13-ijmm-45-04-1187","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/cncr.32130","article-title":"Antitumor efficacy of arsenic\/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors","volume":"125","author":"El Eit","year":"2019","journal-title":"Cancer"},{"key":"key20200713162517_b14-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7150\/ijbs.5613","article-title":"Interferon induced IFIT family genes in host antiviral defense","volume":"9","author":"Zhou","year":"2013","journal-title":"Int J Biol Sci"},{"key":"key20200713162517_b15-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.1074\/jbc.M110.207068","article-title":"The interferon stimulated gene 54 promotes apoptosis","volume":"286","author":"Stawowczyk","year":"2011","journal-title":"J Biol Chem"},{"key":"key20200713162517_b16-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"383","DOI":"10.7150\/ijbs.17236","article-title":"Inhibition of proteasome activity induces aggregation of IFIT2 in the centrosome and enhances IFIT2-induced cell apoptosis","volume":"13","author":"Chen","year":"2017","journal-title":"Int J Biol Sci"},{"key":"key20200713162517_b17-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The world health organization (WHo) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"key20200713162517_b18-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"674","DOI":"10.7150\/ijms.23782","article-title":"Inhibition of CRL-NEDD8 pathway as a new approach to enhance ATRA-induced differentiation of acute promyelocytic leukemia cells","volume":"15","author":"Liu","year":"2018","journal-title":"Int J Med Sci"},{"key":"key20200713162517_b19-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713162517_b20-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1182\/blood-2004-04-1242","article-title":"The Jab1\/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression","volume":"105","author":"Tomoda","year":"2005","journal-title":"Blood"},{"key":"key20200713162517_b21-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1006\/bbrc.2000.2576","article-title":"Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1)","volume":"270","author":"Morimoto","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713162517_b22-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000486219","article-title":"Decreased IFIT2 expression promotes gastric cancer progression and predicts poor prognosis of the patients","volume":"45","author":"Chen","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"key20200713162517_b23-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41419-017-0107-3","article-title":"PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2","volume":"9","author":"Shen","year":"2018","journal-title":"Cell Death Dis"},{"key":"key20200713162517_b24-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"100176","DOI":"10.18632\/oncotarget.22122","article-title":"Decreased expression of interferon-induced protein 2 (IFIT2) by Wnt\/\u03b2-catenin signaling confers anti-apoptotic properties to colorectal cancer cells","volume":"8","author":"Ohsugi","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713162517_b25-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/15384047.2016.1276129","article-title":"Curcumin induces apoptosis in human leukemic cell lines through an IFIT2-dependent pathway","volume":"18","author":"Zhang","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"key20200713162517_b26-ijmm-45-04-1187","first-page":"119","article-title":"EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL\/PI3K\/AKT\/mTOR pathway","volume":"39","author":"Huang","year":"2018","journal-title":"Oncol Rep"},{"key":"key20200713162517_b27-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","article-title":"p27, a novel inhibitor of g1 cyclin-Cdk protein kinase activity, is related to p21","volume":"78","author":"Toyoshima","year":"1994","journal-title":"Cell"},{"key":"key20200713162517_b28-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ng.2350","article-title":"The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells","volume":"44","author":"Zhang","year":"2012","journal-title":"Nat Genet"},{"key":"key20200713162517_b29-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4161\/cc.7.2.5148","article-title":"PI3K\/Akt\/ FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27(Kip1)","volume":"7","author":"Nakao","year":"2008","journal-title":"Cell Cycle"},{"key":"key20200713162517_b30-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/nm759","article-title":"PKB\/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization","volume":"8","author":"Shin","year":"2002","journal-title":"Nat Med"},{"key":"key20200713162517_b31-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/emboj\/18.1.188","article-title":"c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms","volume":"18","author":"Wisdom","year":"1999","journal-title":"EMBO J"},{"key":"key20200713162517_b32-ijmm-45-04-1187","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1074\/jbc.M109.029280","article-title":"Mitogenic regulation of p27(Kip1) gene is mediated by AP-1 transcription factors","volume":"285","author":"Khattar","year":"2010","journal-title":"J Biol Chem"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T20:45:28Z","timestamp":1695761128000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2020.4500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":32,"URL":"https:\/\/doi.org\/10.3892\/ijmm.2020.4500","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]}}}